Effect of chronic activation of 5-HT 3 receptors on 5-HT 3, 5-HT 1A and 5-HT 2A receptors functional activity and expression of key genes of the brain serotonin system

Neuroscience Letters

Volumn 522, Issue 1, 2012, Pages 52-56

  Kondaurova, Elena M ^a   Naumenko, Vladimir S ^a   Popova, Nina K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Brain 5 HT 3, 5 HT 1A, 5HT 2A serotonin receptors; Expression of the 5 HT 3, 5 HT 1A, 5HT 2A, 5 HTT, TPH 2 genes; Receptors functional activity

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE HYDROCHLORIDE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; M CPBG; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN BRAIN LEVEL;

ANIMALS; BIGUANIDES; BRAIN; MICE; MICE, INBRED STRAINS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN 5-HT3 RECEPTOR AGONISTS;

EID: 84863782947     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.015     Document Type: Article

References (44)

1. Abdel-Latif A.A. Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. Pharmacological Reviews 1986, 38:227-272.
2. Aghajanian G. Electrophysiology of serotonin receptor subtypes and signal transduction pathways. Psychopharmacology: The Fourth Generation of Progress 1995, 1451-1459. Raven Press, New York. F.R. Bloom, D.J. Kupfer (Eds.).
3. Andrade R., Chaput Y. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. Journal of Pharmacology and Experimental Therapeutics 1991, 257:930-937.
4. Andrade R., Chaput Y. The electrophysiology of serotonin receptor subtypes. Serotonin Receptor Subtypes: Basic and Clinical Aspects 1991, 103-124. John Wiley Ltd., New York. S.J. Petrouka (Ed.).
5. Anttila S.A., Leinonen E.V. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Reviews 2001, 7:249-264.
6. Aouizerate B., Guehl D., Cuny E., Rougier A., Burbaud P., Tignol J., Bioulac B. Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatry Disease and Treatment 2005, 1:231-243.
7. Baez M., Kursar J.D., Helton L.A., Wainscott D.B., Nelson D.L. Molecular biology of serotonin receptors. Obesity Research 1995, 3(Suppl. 4):441S-447S.
8. 1A-agonistic effects of the new antidepressant mirtazapine. Psychopharmacology 1997, 133:275-282.
9. 1A receptors in augmenting antidepressant activity in the mouse forced swimming test. Psychopharmacology 1998, 136:226-234.
10. Chameau P., van Hooft J.A. Serotonin 5-HT(3) receptors in the central nervous system. Cell and Tissue Research 2006, 326:573-581.
11. Colquhoun D. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. British Journal of Pharmacology 1998, 125:924-947.
12. 3 receptors in drug abuse and as a target for pharmacotherapy. CNS & Neurological Disorders Drug Targets 2008, 7:454-467.
13. 2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. Journal of Pharmacology and Experimental Therapeutics 2010, 335:728-734.
14. Felder C.C., Kanterman R.Y., Ma A.L., Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:2187-2191.
15. Fink K.B., Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacological Reviews 2007, 59:360-417.
16. 3 receptors. Neurochemistry International 1993, 23:373-383.
17. 2A receptors. Journal of Cellular Physiology 1998, 175:341-347.
18. Green A.R., Heal D.J. The effects of drugs on serotonin-mediated behavioural models. Neuropharmacology of Serotonin 1985, 326-365. Oxford University, Oxford. A.R. Green (Ed.).
19. 3 receptor. Biophysical Journal 2003, 84:1720-1733.
20. Hertel P., Nomikos G.G., Schilstrom B., Arborelius L., Svensson T.H. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism. Neuropsychopharmacology 1997, 17:44-55.
21. 2 receptors in trigeminal ganglion neurons of rats. Neuropharmacology 2004, 47:833-840.
22. 3 receptor channel. Annual Review of Physiology 1995, 57:447-468.
23. 3 receptor agonist. European Journal of Pharmacology 1990, 182:193-197.
24. 3 receptors in rat brain using radioligand binding. Nature 1987, 330:746-748.
25. 3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sciences 2002, 72:375-387.
26. 2A serotonin receptor mRNAs using genomic DNA as an external standard. Journal of Neuroscience Methods 2005, 141:97-101.
27. 2 receptors. Brain Research 2006, 1093:105-115.
28. 2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor. Journal of Biological Chemistry 2008, 283:19301-19313.
29. Marek G., Aghajanian G. Electrophysiology of neural systems. Neurobiology of Mental Illness 1999, 26-36. Oxford University Press, New York. D. Charney, E. Nestler, B. Bunney (Eds.).
30. Meller S.T., Lewis S.J., Brody M.J., Gebhart G.F. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Brain Research 1992, 585:71-86.
31. 1A receptor interaction in the suppression of catalepsy. Genes, Brain, and Behavior 2010, 9:519-524.
32. 1A receptor. Neuroscience Letters 2009, 465:50-54.
33. Naumenko V.S., Kulikov A.V. Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Molekuliarnaia Biologiia 2006, 40:37-44.
34. Naumenko V.S., Osipova D.V., Kostina E.V., Kulikov A.V. Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. Journal of Neuroscience Methods 2008, 170:197-203.
35. 2A receptors in the genetic mechanisms of the brain 5-HT system autoregulation. Molekuliarnaia Biologiia 2012, 46:416-422.
36. Nayak S.V., Ronde P., Spier A.D., Lummis S.C., Nichols R.A. Calcium changes induced by presynaptic 5-hydroxytryptamine-3 serotonin receptors on isolated terminals from various regions of the rat brain. Neuroscience 1999, 91:107-117.
37. Overstreet D.H., Rezvani A.H., Knapp D.J., Crews F.T., Janowsky D.S. Further selection of rat lines differing in 5-HT-1A receptor sensitivity: behavioral and functional correlates. Psychiatric Genetics 1996, 6:107-117.
38. Popova N.K., Naumenko V.S., Cybko A.S., Bazovkina D.V. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior. Neuroscience 2010, 169:229-235.
39. 3 receptor in depression: a probable neuronal target?. Journal of Psychopharmacology (Oxford, England) 2010, 24:455-469.
40. Simon A.R., Severgnini M., Takahashi S., Rozo L., Andrahbi B., Agyeman A., Cochran B.H., Day R.M., Fanburg B.L. 5-HT induction of c-fos gene expression requires reactive oxygen species and Rac1 and Ras GTPases. Cell Biochemistry and Biophysics 2005, 42:263-276.
41. Slotnick B.M., Leonard C.M. A Stereotaxic Atlas of the Albino Mouse Forebrain 1975, U.S. Department of Health, Education and Welfare, Rockville, MD, 174 pp.
42. 3 receptor-mediated response and trafficking by activation of protein kinase C. Journal of Biological Chemistry 2003, 278:34150-34157.
43. Zhang Y., D'Souza D., Raap D.K., Garcia F., Battaglia G., Muma N.A., Van de Kar L.D. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation. Journal of Neuroscience 2001, 21:7919-7927.
44. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacological Reviews 1992, 44:401-458.